Emergent BioSolutions Inc. is strengthening its commitment to widespread opioid emergency preparedness by collaborating with partners to expand access to NARCAN Nasal Spray. These efforts are underway as opioid overdose death rates continue to decline nationwide for the first time in five years.
Recognizing the high risk within the construction industry, Emergent is supporting the NYC Building & Construction Industry Safety Fund in launching its new educational program, HOPE/LIVES. This initiative will provide training to workers on overdose signs and NARCAN administration, along with opioid emergency kits containing two doses of the medication.
Additionally, Emergent is partnering with Pathway Healthcare to equip its network of Mississippi locations with NARCAN Nasal Spray, ensuring treatment is readily available for patients and families impacted by opioid use disorder. These collaborations aim to make life-saving interventions more accessible and foster a supportive environment.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.